Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by HighteawithIntrepid on Jul 23, 2015 7:56am

RTF

My belief is we went through an informal RTF process when we did the plant review and all the fiddling bits are under control. My G&M says July 23. So: We're another day along the path 60-1-23 =36 days to go as of 4:00 pm.
Comment by princeofcut on Jul 23, 2015 10:25am
HT, i doubt TST's plant/mfg will cause an RTF, i suspect it if happens it will be related to other data...as best i know "unmet need" is not really a consideration for intial review to determine if a full review can be done...you should take a few hours to research and understand the FDA BLA review for marketing approval system...there is lots of info around including good ...more  
Comment by princeofcut on Jul 23, 2015 11:08am
HT and to further laugh at the bagholders on this sad MB who prefer to whine and cry like arhtur regarding Santa and meetings with incompetent ex-CEO and victim garbage like that, here is a morsel of what i have found before to help frame this "investment opportunity":  this below from a basic and very good research report: "Priority and Fast-Track products have higher first ...more  
Comment by princeofcut on Jul 23, 2015 12:21pm
ht, and as a final laugh at all the pathetic bagholders on this MB i will leave you with this tibbit: "Orphan drug and Fee-Waiver designations however, did not lead to similar outcomes with only 33% and 12% first-cycle approval rates, respectively."...go find the study yourself ..again only scumbag fraudster bagholders acccuse me of being a basher (they are 100% wrong which is why i ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities